Longitudinal association between lung function and health-related quality of life in cystic fibrosis

Thorax

Volumn 68, Issue 2, 2013, Pages 149-154

  Abbott, Janice ^a   Hurley, Margaret A ^a   Morton, Alison M ^b   Conway, Steven P ^b  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; POPULATION SIZE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; VALIDITY;

EID: 84872675202     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202552     Document Type: Article

References (35)

1. Rosenstein BL, Zeitlin PL. Cystic fibrosis. Lancet 1998;351:277-82.
2. UK Cystic Fibrosis Registry. Annual Data Report 2010. Cystic Fibrosis Trust 2012.
3. Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009;8:91-6.
4. Sawicki GS, Tiddens H. Managing treatment complexity in cystic fibrosis: challenges and opportunities. Pediatr Pulmonol 2012;47:523-33.
5. Abbott J, Hart A, Havermans T, et al. Measuring health-related quality of life in clinical trials in cystic fibrosis. J Cyst Fibros 2011;10;S82-5.
6. Abbott J, Hart A, Morton AM, et al. Can health-related quality of life predict survival in adults with cystic fibrosis. Am J Respir Crit Care Med 2009;179:54-8.
7. Quittner A, Buu A, Messer M, et al. Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005;128:2347-54.
8. Goldbeck L, Schmitz TG. Comparison of three generic questionnaires measuring quality of life in adolescents and adults with cystic fibrosis: the 36-item short form health survey, the quality of life profile for chronic diseases, and the questions on life satisfaction. Qual Life Res 2001;10:23-36.
9. Gee L, Abbott J, Conway S, et al. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000;55:946-54.
10. Gee L, Abbott J, Conway SP, et al. Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. J Cyst Fibros 2003;2:206-13.
11. Staab D, Wenninger K, Gerbert N, et al. Quality of life in patients with cystic fibrosis and their parents; what is important besides disease severity. Thorax 1998;53:727-31.
12. Bradley J, McAlister O, Elborn S. Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis. Eur Respir J 2001;17:712-15.
13. Schmitz TG, Henrich G, Goldbeck L. Quality of life with cystic fibrosis - aspects of age and gender. Klinische Padiatrie 2006;218:7-12.
14. Gee L, Abbott J, Hart A, et al. Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros 2005;4:59-66.
15. Goldbeck L, Zerrer S, Schmitz TG. Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results. J Cyst Fibros 2007;6:171-8.
16. Congleton J, Hodson ME, Duncan-Skingle F. Do Nottingham Health Profile scores change over time in cystic fibrosis? Respir Med 1998;92:268-72.
17. Sawicki GS, Rasouliyan L, McMullen AH, et al. Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis. Pediatr Pulmonol 2011;46:36-44.
18. Que C, Cullinan P, Geddes D. Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax 2006;61:155-7.
19. Rosenbluth DB, Wilson K, Ferkol T, et al. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 2004;126:412-19.
20. Britto MT, Kotagal UR, Hornung RW, et al. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest 2002;121:64-72.
21. Arrington-Sanders R, Yi MS, Tsevat J, et al. Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Out 2006;4:5.
22. Abbott J, Conway S, Etherington C, et al. Nutritional status, perceived body image and eating behaviours in adults with cystic fibrosis. Clin Nutr 2007;26:91-9.
23. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. 2nd edn., New Jersey: Wiley Series in Probability, 2011.
24. Kreft I, De Leeuw J. Introducing multilevel modelling. London: Sage Publications, 1998.
25. Walters SJ. Quality of life outcomes in clinical trials and health care evaluation: a practical guide to health care interpretation. Chichester: Wiley, 2009.
26. Rasbash J, Charlton C, Browne WJ, et al. MLwiN Version 2.1. Centre for multilevel modelling. University of Bristol, 2009.
27. Littlewood JM, MacDonald A. Rationale of modern dietary recommendations in cystic fibrosis. J R Soc Med 1987;80:16-24.
28. Bowling A, Bond M, Jenkinson C, et al. Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the omnibus survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey. J Public Health Med 1999;21:255-70.
29. Suri R, Metcalf C, Wallis C, et al. A. Assessing the usefulness of outcomes measured in a cystic fibrosis treatment trial. Respir Med 2007;101:254-60.
30. Herrman H, Stewart DE, Diaz-Granados N, et al. What is resilience? Can J Psychiatry 2011;56:258-65.
31. Abbott J, Hart A, Morton A, et al. Health-related quality of life in adults with cystic fibrosis: the role of coping. J Psychosom Res 2008;64:149-57.
32. Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007;132:231-7.
33. Dasenbrook EC, Merlo CA, Diener-West M, et al. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008;178:814-21.
34. Kalish LA, Waltz D A, Dovey M, et al. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med 2006;173:421-5.
35. Waters V, Stanojevic S, Atenafu EG, et al. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J 2012;40:61-6.